Bosutinib
From Self-sufficiency
| File:Bosutinib.png | |
| Systematic (IUPAC) name | |
|---|---|
|
4-[(2,4-dichloro-5-methoxyphenyl)amino]-6-methoxy-7-[3-(4-methylpiperazin-1-yl)propoxy]quinoline-3-carbonitrile | |
| Identifiers | |
| CAS Number | 380843-75-4 |
| ATC code | none |
| PubChem | CID 5328940 |
| Chemical data | |
| Formula | C26H29Cl2N5O3 |
| Molar mass | 530.446 g/mol[[Script error: No such module "String".]] |
Bosutinib (rINN/USAN; codenamed SKI-606) is a tyrosine kinase inhibitor undergoing research for use in the treatment of cancer.[1]
It is being developed by Wyeth.
References
Cite error: Invalid <references> tag;
parameter "group" is allowed only.
<references />, or <references group="..." />External links
- http://www.eurekalert.org/pub_releases/2007-12/uotm-epi120707.php
- http://professional.cancerconsultants.com/oncology_main_news.aspx?id=39941
 |
This pharmacology-related article is a stub. You can help ssf by expanding it. |
- ↑ Lua error in package.lua at line 80: module 'Module:Citation/CS1/Suggestions' not found.
Categories:
- Pages with script errors
- Pages with broken file links
- Infobox drug tracked parameters
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs not assigned an ATC code
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- 2Fix
- Cancer treatments
- Tyrosine kinase inhibitors
- Piperazines
- Phenol ethers
- Quinolines
- Nitriles
- Aromatic amines
- Organochlorides
- Pharmacology stubs
